• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抑制细菌肽聚糖合成并由链霉菌产生的新型脂霉素。II. 分离与结构解析。

New types of liposidomycins that inhibit bacterial peptidoglycan synthesis and are produced by Streptomyces. II. Isolation and structure elucidation.

作者信息

Kimura K, Ikeda Y, Kagami S, Yoshihama M, Ubukata M, Esumi Y, Osada H, Isono K

机构信息

Research Institute of Life Science, Snow Brand Milk Products Co., Ltd., Tochigi, Japan.

出版信息

J Antibiot (Tokyo). 1998 Jul;51(7):647-54. doi: 10.7164/antibiotics.51.647.

DOI:10.7164/antibiotics.51.647
PMID:9727391
Abstract

Various new liposidomycins were isolated from a culture of the strain Streptomyces sp. SN-1061M by changing medium components and they were classified into four types (I-IV) based on their structures. They were purified by butanol extraction, silica gel and LH-20 column chromatographies, and high performance liquid chromatography on ODS columns. Type (I) has the original structure which has sulfate and 3-methylglutaric acid moieties. Type (II) has no 3-methylglutaric acid moiety and type (III) has no sulfate moiety. Type (IV) has neither moiety. Type (III) and (IV) compounds, which have no sulfate moiety, exhibited more potent antimicrobial activity.

摘要

通过改变培养基成分,从链霉菌属菌株SN-1061M的培养物中分离出了多种新型脂霉素,并根据其结构将它们分为四种类型(I-IV)。通过丁醇萃取、硅胶柱色谱和LH-20柱色谱以及ODS柱上的高效液相色谱对它们进行了纯化。类型(I)具有原始结构,含有硫酸根和3-甲基戊二酸部分。类型(II)没有3-甲基戊二酸部分,类型(III)没有硫酸根部分。类型(IV)两者都没有。没有硫酸根部分的类型(III)和(IV)化合物表现出更强的抗菌活性。

相似文献

1
New types of liposidomycins that inhibit bacterial peptidoglycan synthesis and are produced by Streptomyces. II. Isolation and structure elucidation.抑制细菌肽聚糖合成并由链霉菌产生的新型脂霉素。II. 分离与结构解析。
J Antibiot (Tokyo). 1998 Jul;51(7):647-54. doi: 10.7164/antibiotics.51.647.
2
New types of liposidomycins that inhibit bacterial peptidoglycan synthesis and are produced by Streptomyces. I. Producing organism and medium components.新型脂霉素,可抑制细菌肽聚糖合成,由链霉菌产生。I. 产生菌及培养基成分。
J Antibiot (Tokyo). 1998 Jul;51(7):640-6. doi: 10.7164/antibiotics.51.640.
3
New types of liposidomycins produced by Streptomyces that inhibit bacterial peptidoglycan synthesis. Structure elucidation of fatty acid components by tandem mass spectrometry.链霉菌产生的新型脂霉素可抑制细菌肽聚糖合成。通过串联质谱法对脂肪酸成分进行结构解析。
J Antibiot (Tokyo). 1999 Mar;52(3):281-7. doi: 10.7164/antibiotics.52.281.
4
Cedarmycins A and B, new antimicrobial antibiotics from Streptomyces sp. TP-A0456.雪松霉素A和B,来自链霉菌属TP-A0456的新型抗菌抗生素。
J Antibiot (Tokyo). 2001 Jul;54(7):567-72. doi: 10.7164/antibiotics.54.567.
5
Mansoquinone: isolation and structure elucidation of new antibacterial aromatic polyketides from terrestrial Streptomyces Sp. Eg5.曼索醌:从陆生链霉菌属菌株Eg5中分离并鉴定新型抗菌芳香聚酮化合物的结构
Nat Prod Res. 2009;23(3):212-8. doi: 10.1080/14786410801961550.
6
Selective inhibition of the bacterial peptidoglycan biosynthesis by the new types of liposidomycins.新型脂肽霉素对细菌肽聚糖生物合成的选择性抑制作用。
J Antibiot (Tokyo). 1998 Dec;51(12):1099-104. doi: 10.7164/antibiotics.51.1099.
7
Liposidomycins: novel nucleoside antibiotics which inhibit bacterial peptidoglycan synthesis.
J Antibiot (Tokyo). 1985 Nov;38(11):1617-21. doi: 10.7164/antibiotics.38.1617.
8
Secondary metabolites by chemical screening, 15. Structure and absolute configuration of naphthomevalin, a new dihydro-naphthoquinone antibiotic from Streptomyces sp.通过化学筛选的次生代谢产物,15. 萘甲缬氨酸的结构与绝对构型,一种来自链霉菌属的新型二氢萘醌抗生素
J Antibiot (Tokyo). 1991 Jun;44(6):665-9. doi: 10.7164/antibiotics.44.665.
9
Deacetylravidomycin M, a new inhibitor of IL-4 signal transduction, produced by Streptomyces sp. WK-6326. I. Taxonomy, fermentation, isolation and biological activities.去乙酰拉维多霉素M,一种由链霉菌属WK-6326产生的白细胞介素-4信号转导新抑制剂。I. 分类学、发酵、分离及生物活性。
J Antibiot (Tokyo). 2001 Jul;54(7):554-61. doi: 10.7164/antibiotics.54.554.
10
CV-1, a new antibiotic produced by a strain of Streptomyces sp. I. Fermentation, isolation and biological properties of the antibiotic.CV - 1,一种由链霉菌属菌株产生的新型抗生素。I. 抗生素的发酵、分离及生物学特性
J Antibiot (Tokyo). 1987 Jun;40(6):723-6. doi: 10.7164/antibiotics.40.723.

引用本文的文献

1
New liposidomycin congeners produced by Streptomyces sp. TMPU-20A065, anti-Mycobacterium avium complex agents with therapeutic efficacy in a silkworm infection model.新型脂肽类化合物由链霉菌 sp. TMPU-20A065 产生,对结核分枝杆菌复合群具有抗药性,在蚕感染模型中具有治疗效果。
J Antibiot (Tokyo). 2024 Jul;77(7):412-421. doi: 10.1038/s41429-024-00724-4. Epub 2024 May 8.
2
Structures of Bacterial MraY and Human GPT Provide Insights into Rational Antibiotic Design.细菌 MraY 和人类 GPT 的结构为合理设计抗生素提供了线索。
J Mol Biol. 2020 Aug 21;432(18):4946-4963. doi: 10.1016/j.jmb.2020.03.017. Epub 2020 Mar 19.
3
Chemical logic of MraY inhibition by antibacterial nucleoside natural products.
抗菌核苷天然产物抑制 MraY 的化学逻辑。
Nat Commun. 2019 Jul 2;10(1):2917. doi: 10.1038/s41467-019-10957-9.
4
A comprehensive review of glycosylated bacterial natural products.糖基化细菌天然产物的全面综述。
Chem Soc Rev. 2015 Nov 7;44(21):7591-697. doi: 10.1039/c4cs00426d.
5
Structure-based gene targeting discovery of sphaerimicin, a bacterial translocase I inhibitor.基于结构的基因靶向发现螺旋霉素,一种细菌易位酶 I 抑制剂。
Angew Chem Int Ed Engl. 2013 Oct 25;52(44):11607-11. doi: 10.1002/anie.201305546. Epub 2013 Sep 6.
6
The muraminomicin biosynthetic gene cluster and enzymatic formation of the 2-deoxyaminoribosyl appendage.穆拉米诺霉素生物合成基因簇及2-脱氧氨基核糖基附属物的酶促形成。
Medchemcomm. 2013 Jan 1;4(1):239-243. doi: 10.1039/C2MD20245J. Epub 2012 Sep 26.
7
Identification and manipulation of the caprazamycin gene cluster lead to new simplified liponucleoside antibiotics and give insights into the biosynthetic pathway.对卡普霉素基因簇的鉴定和操作产生了新的简化型脂环核苷抗生素,并为生物合成途径提供了见解。
J Biol Chem. 2009 May 29;284(22):14987-96. doi: 10.1074/jbc.M901258200. Epub 2009 Apr 7.